BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
latest_posts
- 1
One spent $20 on candy. Another paid $700 for a custom costume. Here's how Halloween costs stacked up this year. - 2Marvel's X-Men are joining the battle in 'Avengers: Doomsday': Watch the teaser
- 3Takeaways from AP’s report on potential impacts of Alaska’s proposed Ambler Access Road
- 4A definitive Manual for Well known Fragrances
- 58 Fundamental Stages: Novice's Manual for Secure Your Android with a VPN
- Investigation reveals sperm donor passed on cancer risk to dozens of children across Europe
- He suddenly couldn't speak in space. NASA astronaut says his medical scare remains a mystery
- San Francisco sues 10 companies that make ultraprocessed food
- Russia patents space station designed to generate artificial gravity
- Ancient Egyptian pharaoh's boat is being reassembled in public at the Grand Egyptian Museum
- Pedal Power: Divulging Well known Bike Brands for Each Cyclist
- ‘Downton Abbey: The Grand Finale’ hits streaming: How to watch, cast info and everything you need to know
- Sean Penn lights up, Kylie Jenner gets A-list approval and 7 other moments you didn’t see at the Golden Globes
- Chicago reports first rabies-positive dog in 61 years. What we know.
